Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AndrewWLo
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AndrewWLo
-
Thanks for your kind words---you're one of very few viewers who commented that these lectures were taped DURING the Financial Crisis! Every weekend, something huge would happen that we'd have to discuss in class on Mondays (Lehman, AIG, BAC, etc.). Super exciting and stressful!https://twitter.com/mbacandidates/status/1204984653112700928 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Super honored to be recognized with John Hull and
@rogermstein for "Funding Long Shots". Better financial engineering tools are critical for meeting society's biggest challenges---finance isn't a zero-sum game if we play it right!https://www.businesswire.com/news/home/20200128005166/en/Journal-Investment-Management-New-Frontier-Advisors-2019 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Honored to be giving a public lecture tomorrow 6:00pm at
@UCBerkeley's@SimonsInstitute on "Artificial Stupidity: The New AI and the Future of Fintech"; hope to see you there! https://simons.berkeley.edu/events/andrewloHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Honored to work with
@SeanKhozin of@US_FDA and my students Kien Wei Siah and Chi Heem Wong on new pub predicting clinical trial outcomes of lung cancer patients using#AI; PDL1 biomarker is strongest predictor. We can do even better with multi-omics:https://ascopubs.org/doi/full/10.1200/CCI.19.00046 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I'm speaking at
#BostonFinTechWeek2019! Join me for an engaging week of events from 200 orgs across the ecosystem. I'm honored to be joining over 170 experts to share insights on the future of#FinTech and#finance. Register athttp://bit.ly/2Y2p6UQHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Rarely does one get a chance to give a 45-min talk about one's role model and mentor; I had that privilege earlier this month at Bob Merton's 75th birthday celebration. My talk: "Robert C. Merton: The First Financial Engineer". https://bit.ly/2ZGgW1b Thanks, Bob, for my career!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adaptive platform trials are the future of medicine from time, cost, efficacy, and patient perspectives. Truly honored to be part of the APT Coalition that just published an overview of this powerful approach to drug and device development: https://rdcu.be/bPLEu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Honored to have spoken at 2019
@AmazonreMARS on how machine learning predictions of clinical trials outcomes using@Citeline database can reduce the cost of capital for drug development. In case you're on vacation and finished watching#PeakyBlinders, https://www.youtube.com/watch?v=AzELyaVf0v8 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Super proud of my brother Martin, a real rocket scientist, for Brouwer award for “seminal contributions in nonlinear astrodynamics and dynamical astronomy and the using of dynamical systems theory and low energy trajectories to space mission design.”https://astronautical.org/2019/03/18/winners-of-2018-american-astronautical-society-awards-announced/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you've never attended a lecture of Patrick Winston's, you're in for a real treat. He's as inspiring a teacher as he is a researcher, and I would urge anyone who cares about the craft of teaching to watch this maestro at work and learn from his example.https://twitter.com/MIT_CSAIL/status/1152623703441756169 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We lost one of the founding fathers of
#AI today. Patrick Winston was world-class scholar and educator, and an inspiration to all of us at MIT. He taught us so much about the workings of the artificial, but in the end, it is his humanity, stories, grace that we will miss most.https://twitter.com/MIT_CSAIL/status/1152337172575531009 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Thrilled that my article on
#machinelearning predictions of clinical trial outcomes is in the 1st issue of the HARVARD DATA SCIENCE REVIEW, a cool new forum for#DataScience and#ArtificialIntelligence research, practice, and policy. Read now for#free at https://bit.ly/2Kuze2q https://twitter.com/HPDSLab/status/1146159794425860096 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to Neil Kumar and the entire team at
$BBIO and their subs for successful IPO! Great for investors, but even better for patients with rare genetic diseases. Starting with mostly preclinical assets,$BBIO now has 4 in Phase 3! Portfolio theory works, even in biotech.https://twitter.com/JohnCendpts/status/1144266929257046019 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Just updated clinical trial PoS estimates through 2019Q1 with
@citeline data at http://projectalpha.mit.edu (sign up for future alerts). Also, see our new PoS paper just for oncology (https://globalforum.diaglobal.org/issue/may-2019/what-are-the-chances-of-getting-a-cancer-drug-approved/ …). We gotta do better for ovarian, pancreatic, and NSC lung cancer patients!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Really honored to talk with
@JorgeCondeBio, successful#biotech entrepreneur and now GP at@a16z in charge of biotech/computing/healthcare (what a cool role!). Gene therapies are here; "drug mortgages" can make them more affordable, if structured right. https://stm.sciencemag.org/content/8/327/327ps6?_ga=2.142137650.1411932933.1531008000-143576054.1531008000 …https://twitter.com/JorgeCondeBio/status/1134324623078596608 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Agreed, but wouldn't it be interesting to quantify relative contribution of betting style vs. accuracy? Especially in comparison to past Jeopardy champs? By simulating different betting strategies for each champ, we can replay history to see how much better Kelly does.https://twitter.com/EconomPic/status/1131436346109640704 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Master's thesis project: assuming a flexible functional form for his utility, reverse-engineer his risk aversion coefficient implicit in his betting strategy. Ph.D. thesis project: simulating various different betting strategies, test for 1st and 2nd order stochastic dominance.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cool project for undergrad thesis: simulate his performance but assuming a different betting strategy for Daily Doubles: (a) conservative (10% of total); (b) Kelly; (c) random; etc. If it's really second order, the simulations should all yield about the same P&L. https://twitter.com/CliffordAsness/status/1130962889437847552 …
Tweet je nedostupan.Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Super important paper on how drugs are made, by former dean of
@harvardmed so he should know!@ncats provides even more detailed map of the ecosystem involved at https://4dmap.ncats.nih.gov/#/ . One more group to add: philanthropists and patient advocates, like@gates &@CF_Foundation.https://twitter.com/jflier/status/1130569791914336260 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.